Today, we are going to forecast the Novavax stock price prediction targets for 2025 to 2030 as part of a long-term outlook. We’ll also analyze the future potential of Novavax stock, including whether it’s a good time to buy or sell. Additionally, we will consider analyst recommendations for the Novavax stock prediction 2025.
Novavax Stock Price Today
About Novavax
Novavax is a biotechnology company based in the USA that makes vaccines to protect people from infectious diseases. It is known for creating protein-based vaccines, which work by teaching the body to fight viruses safely. Novavax became popular during the COVID-19 pandemic for developing a vaccine that helped people stay safe.
The company focuses on research, development, and delivery of safe and effective vaccines worldwide. With advanced technology and a strong team, Novavax works to improve global health and prevent future outbreaks. Their mission is to provide affordable and reliable vaccines to people around the world.
Financial of Novavax
Analyst: Novavax Stock Prediction 2025
Target high is the top price analysts expect and target low is the lowest. Target mean is the average price and target mean is the average value. Recommendation mean (usually 1 = strong buy, 5 = strong sell) shows average rating and recommendation key shows overall view like underperform. Analyst count means Total number of analysts who gave their opinion.
Find Stock Prediction 2025
To stay updated with the latest information related to the stock market and receive live stock market updates, follow Sharedhan and stay connected with us.
Disclaimer: I would like to remind you that I am not authorized by SEC to provide any financial advice or recommendations. The Novavax Stock Prediction are shared for informational purposes only. This does not count as a recommendation to buy, sell or hold the stock. Investors should do their own research, analysis and consult financial experts before making any investment decisions.